Učitavanje...

EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR

Oncogenic alterations of epidermal growth factor receptor (EGFR) signaling are frequently observed in lung cancer patients with worse differentiation and poor prognosis. However, the therapeutic efficacy of EGFR-tyrosine kinase inhibitors (TKIs) is currently limited in selected patients with EGFR mu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Jo, Ukhyun, Park, Kyong Hwa, Whang, Young Mi, Sung, Jae Sook, Won, Nam Hee, Park, Jong Kuk, Kim, Yeul Hong
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012721/
https://ncbi.nlm.nih.gov/pubmed/24658031
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!